5-methoxypsoralen

5-甲氧基补骨脂素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Name5-methoxypsoralen
Drug Alias NameBergapten5-甲氧补骨脂素Psoraderm5-MOP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPsoriasisVitiligoDermatitis, Atopic +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Expanscience Sa
China Registration ClassN/A

Develop Information

Active IndicationsPsoriasisVitiligoSkin Neoplasms +[4
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeD05AD